Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, DNA Repair Mechanisms, Cancer Immunotherapy and Biomarkers, and Gene expression and cancer classification.
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
The evolution of lung cancer and impact of subclonal selection in TRACERx
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
The evolution of non-small cell lung cancer metastases in TRACERx
Body composition and lung cancer-associated cachexia in TRACERx
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
Pervasive chromosomal instability and karyotype order in tumour evolution
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
Artificial intelligence in cancer imaging: Clinical challenges and applications
Neoantigen-directed immune escape in lung cancer evolution
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
A clonal expression biomarker associates with lung cancer mortality
Chromosomal instability drives metastasis through a cytosolic DNA response
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
Tracking the Evolution of Non–Small-Cell Lung Cancer
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Revisiting inconsistency in large pharmacogenomic studies
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Revisiting inconsistency in large pharmacogenomic studies
Assessment of pharmacogenomic agreement
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution